Carregant...
Protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH Domain of Akt1
Ligands that can selectively bind to proteins with single amino acid point mutations offer the potential to detect or treat an abnormal protein in the presence of the wildtype. However, it is difficult to develop a selective ligand if the point mutation is not associated with an addressable location...
Guardat en:
| Publicat a: | Nat Chem |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4408887/ https://ncbi.nlm.nih.gov/pubmed/25901825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchem.2223 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|